WBUR, October 23, 2012

Records show that inspectors knew about problems with an injectable steroid produced at the New England Compounding Center going back to 2002. The same tainted drug allegedly to blame for 23 meningitis deaths. Both documents, as well as testimony before a congressional committee, suggest a pattern of violations and modest penalties for the Framingham specialty pharmacy.

Facebook icon
LinkedIn icon
Twitter icon